![]() |
|
|
Vol. 287, Issue 3, 1105-1112, December 1998
1) Promotes
IL-2 mRNA Expression Through the Up-regulation of NF-
B, AP-1 and
NF-AT in EL4 Cells1
Dept. of Pharmacology & Toxicology and the Dept. of Pathology,
Michigan State University, East Lansing, Michigan
Transforming growth factor
1 (TGF-
1) has been previously shown to
modulate interleukin 2 (IL-2) secretion by activated T-cells. In the
present studies, we determined that TGF-
1 induced IL-2 mRNA
expression in the murine T-cell line EL4, in the absence of other
stimuli. IL-2 mRNA expression was significantly induced by TGF-
1
(0.1-1 ng/ml) over a relatively narrow concentration range, which led
to the induction of IL-2 secretion. Under identical condition, we
examined the effect of TGF-
1 on the activity of nuclear factor AT
(NF-AT), nuclear factor
B (NF-
B), activator protein-1 (AP-1) and
octamer, all of which contribute to the regulation of IL-2 gene
expression. Electrophoretic mobility shift assays showed that TGF-
1
markedly increased NF-AT, NF-
B and AP-1 binding to their respective
cognate DNA binding sites, whereas octamer binding remained constant,
as compared with untreated cells. Employing a reporter gene expression
system with p(NF-
B)3-CAT, p(NF-AT)3-CAT and
p(AP-1)3-CAT, TGF-
1 treatment of transfected EL4 cells
induced a dose-related increase in chloramphenicol acetyltransferase
activity that correlated well with the DNA binding profile found in the electrophoretic mobility shift assay studies. These results show that
TGF-
1, in the absence of any additional stimuli, up-regulates the
activity of key transcription factors involved in IL-2 gene expression,
including NF-AT, NF-
B and AP-1, to help promote IL-2 mRNA expression
by EL4 cells.
This article has been cited by other articles:
![]() |
S. Hong, C. Lee, and S.-J. Kim Smad7 Sensitizes Tumor Necrosis Factor Induced Apoptosis through the Inhibition of Antiapoptotic Gene Expression by Suppressing Activation of the Nuclear Factor-{kappa}B Pathway Cancer Res., October 1, 2007; 67(19): 9577 - 9583. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, L. G. Burdelya, S. M. Swiatkowski, A. D. Boiko, P. H. Howe, G. R. Stark, and A. V. Gudkov Secreted transforming growth factor {beta}2 activates NF-{kappa}B, blocks apoptosis, and is essential for the survival of some tumor cells PNAS, May 4, 2004; 101(18): 7112 - 7117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanaka, H. Kobayashi, M. Suzuki, N. Kanayama, and T. Terao Transforming Growth Factor-{beta}1-dependent Urokinase Up-regulation and Promotion of Invasion Are Involved in Src-MAPK-dependent Signaling in Human Ovarian Cancer Cells J. Biol. Chem., March 5, 2004; 279(10): 8567 - 8576. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Monteleone, J. Mann, I. Monteleone, P. Vavassori, R. Bremner, M. Fantini, G. Del Vecchio Blanco, R. Tersigni, L. Alessandroni, D. Mann, et al. A Failure of Transforming Growth Factor-{beta}1 Negative Regulation Maintains Sustained NF-{kappa}B Activation in Gut Inflammation J. Biol. Chem., February 6, 2004; 279(6): 3925 - 3932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fleischer, E. Grage-Griebenow, B. Kasper, H. Heine, M. Ernst, E. Brandt, H.-D. Flad, and F. Petersen Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells J. Immunol., July 15, 2002; 169(2): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Adib-Conquy, K. Asehnoune, P. Moine, and J.-M. Cavaillon Long-term-impaired expression of nuclear factor-{kappa}B and I{kappa}B{alpha} in peripheral blood mononuclear cells of trauma patients J. Leukoc. Biol., July 1, 2001; 70(1): 30 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mao, J. Van de Water, C. L. Keen, H. H. Schmitz, and M. E. Gershwin Cocoa Procyanidins and Human Cytokine Transcription and Secretion J. Nutr., August 1, 2000; 130(8): 2093S - 2099. [Abstract] [Full Text] |
||||
![]() |
S. S. Yea, K.-H. Yang, and N. E. Kaminski Role of Nuclear Factor of Activated T-Cells and Activator Protein-1 in the Inhibition of Interleukin-2 Gene Transcription by Cannabinol in EL4 T-Cells J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 597 - 605. [Abstract] [Full Text] |
||||